{"id":470562,"date":"2021-04-05T07:03:27","date_gmt":"2021-04-05T11:03:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470562"},"modified":"2021-04-05T07:03:27","modified_gmt":"2021-04-05T11:03:27","slug":"taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/","title":{"rendered":"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences"},"content":{"rendered":"

<\/p>\n

Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences<\/b><\/p>\n

20th<\/sup> Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021 at 10:15 am ET<\/i><\/p>\n

Chardan 5th<\/sup> Annual Manufacturing Summit on Monday, April 26, 2021 at 1:00 pm ET<\/i><\/p>\n

DALLAS–(BUSINESS WIRE<\/a>)–
\nTaysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in virtual fireside chats for the 20th<\/sup> Annual Needham Virtual Healthcare Conference and the Chardan 5th<\/sup> Annual Manufacturing Summit.\n<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Conferences Details:<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

\nEvent:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n20th<\/sup> Annual Needham Virtual Healthcare Conference\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nMonday, April 12, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n10:15 am ET\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nFormat:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nFireside chat\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nParticipants:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nRA Session II, President, Founder and CEO\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nEvent:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nChardan 5th<\/sup> Annual Manufacturing Summit\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nMonday, April 26, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\n1:00 pm ET\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nFormat:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nFireside chat\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nParticipants:\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nRA Session II, President, Founder and CEO\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nFred Porter, Ph.D., Chief Technical Officer\n<\/p>\n<\/td>\n<\/tr>\n

\n

\n\u00a0\n<\/p>\n<\/td>\n

\u00a0<\/td>\n\n

\nGreg Gara, Senior Vice President of Manufacturing\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nWebcasts for these conferences will be available in the \u201cEvents & Media\u201d section of the Taysha corporate website at https:\/\/ir.tayshagtx.com\/news-events\/events-presentations<\/a>. Archived versions of the webcasts will be available on the website for 60 days.\n<\/p>\n

About Taysha Gene Therapies <\/b><\/p>\n

\nTaysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team\u2019s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform\u2014an engine for potential new cures\u2014with a goal of dramatically improving patients\u2019 lives. More information is available at www.tayshagtx.com<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210405005218\/en\/<\/a><\/span><\/p>\n

Company Contact:
\n<\/b>
Kimberly Lee, D.O.
\n
SVP, Corporate Communications and Investor Relations
\n
Taysha Gene Therapies
\n
klee@tayshagtx.com<\/a><\/p>\n

Media Contact:
\n<\/b>
Carolyn Hawley
\n
Canale Communications
\n
carolyn.hawley@canalecomm.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Texas<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Genetics Other Health General Health Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021 at 10:15 am ET Chardan 5th Annual Manufacturing Summit on Monday, April 26, 2021 at 1:00 pm ET DALLAS–(BUSINESS WIRE)– Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in virtual fireside chats for the 20th Annual Needham Virtual Healthcare Conference and the Chardan 5th Annual Manufacturing Summit. Conferences Details: Event: \u00a0 20th Annual Needham Virtual Healthcare Conference Date: \u00a0 Monday, April 12, 2021 … <\/p>\n

Continue reading “Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470562","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTaysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021 at 10:15 am ET Chardan 5th Annual Manufacturing Summit on Monday, April 26, 2021 at 1:00 pm ET DALLAS–(BUSINESS WIRE)– Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in virtual fireside chats for the 20th Annual Needham Virtual Healthcare Conference and the Chardan 5th Annual Manufacturing Summit. Conferences Details: Event: \u00a0 20th Annual Needham Virtual Healthcare Conference Date: \u00a0 Monday, April 12, 2021 … Continue reading "Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-05T11:03:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences\",\"datePublished\":\"2021-04-05T11:03:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/\"},\"wordCount\":375,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/\",\"name\":\"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-04-05T11:03:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences - Market Newsdesk","og_description":"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences 20th Annual Needham Virtual Healthcare Conference on Monday, April 12, 2021 at 10:15 am ET Chardan 5th Annual Manufacturing Summit on Monday, April 26, 2021 at 1:00 pm ET DALLAS–(BUSINESS WIRE)– Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in virtual fireside chats for the 20th Annual Needham Virtual Healthcare Conference and the Chardan 5th Annual Manufacturing Summit. Conferences Details: Event: \u00a0 20th Annual Needham Virtual Healthcare Conference Date: \u00a0 Monday, April 12, 2021 … Continue reading \"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-05T11:03:27+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences","datePublished":"2021-04-05T11:03:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/"},"wordCount":375,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/","name":"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-04-05T11:03:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210405005218r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/taysha-gene-therapies-to-participate-in-upcoming-april-investor-healthcare-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470562"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470562\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}